Cidara Therapeutics and Melinta Therapeutics Announce FDA Approval of REZZAYO™ …
<!-- Name:DistributionId Value:8793824 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Cidara
Cidara Therapeutics Nominates First Oncology Clinical Development Candidate from its…
SAN DIEGO, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to improve the standard of care…
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2022…
SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to help improve the standard of…
Cidara Therapeutics to Present New Data for Rezafungin at TIMM Congress
SAN DIEGO, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to improve the standard of…